Journal of Natural Medicines (2021) 75:339–343
343
CDCl3) δ 7.73 (d, J = 8.1 Hz, 2H), 7.29 (d, J = 8.1 Hz,
2H), 4.75 (d, J = 8.3, 1H), 4.03 (m, 2H), 3.80 (s, 1H), 3.62
(dd, J = 10.0, 3.7 Hz, 1H), 3.48 (dd, J = 10.0, 6.2 Hz, 1H),
2.39 (s, 3H), 1.36 (s, 9H), 0.77 (s, 9H), − 0.04 (s, 6H);
13C NMR (100 MHz, CDCl3) δ 155.1, 145.0, 132.6, 130.0,
128.0, 79.8, 67.9, 60.9, 50.4, 28.3, 25.8, 21.7, 18.1, 14.2,
5.6; HRMS (ESI) calcd for C21H37NO6SiSNa+ [M + Na]+
482.2003, found 482.1961.
References
1. Fosgerau K, Hofmann T (2015) Peptide therapeutics: current status
and future directions. Drug Discov Today 20:122–128
2. Dang T, Sussmuth RD (2017) Bioactive peptide natural products as
lead structures for medicinal use. Acc Chem Res 50:1566–1576
3. Pan C, Kuranaga T, Liu C, Lu S, Shinzato N, Kakeya H (2020) Thio-
amycolamides A–E, sulfur-containing cycliclipopeptides produced
by the rare actinomycete Amycolatopsis sp. Org Lett 22:3014–3017
4. Pan C, Kuranaga T, Kakeya H (2020) Total synthesis of thioa-
mycolamide A via a biomimetic route. Org Biomol Chem
18:8366–8370
5. Yamashita T, Kuranaga T, Inoue M (2015) Solid-phase total synthe-
sis of bogorol A: stereocontrolled construction of thermodynami-
cally unfavored (E)-2-amino-2-butenamide. Org Lett 17:2170–2173
6. Boden CDJ, Pattenden G, Ye T (1995) The synthesis of optically
active thiazoline and thiazole derived peptides from N-protected
α-amino acids. Synlett 1995:417–419
Thioethers 14a–d
To a solution of 16 (1.5 mg, 4.4 μmol) and 17 (0.6 mg,
3.4 μmol) in MeCN (100 μL) was added K2CO3 (1.0 mg)
at room temperature. After being stirred for 24 h, the mix-
ture was fltered and concentrated under reduced pressure.
To the residue was added 4 M HCl in dioxane (0.2 mL).
After being stirred at room temperature for 1 h, the sol-
vent was removed under reduced pressure. The obtained
hydrolysate in H2O (100 μL) were added l-FDVDA (5 mg/
mL in acetone, 40 μL) and 1 M NaHCO3 aqueous solution
(20 μL). After being stirred at 50 °C for 2 h, the reaction
was quenched with 2 M HCl (20 μL), evaporated, dis-
solved in MeCN (100 μL), fltered through a membrane
flter (SHIMADZU, TORAST™ DISC, PTFE 0.22 μm) to
give 14a for the LC–MS analysis. Diastereomers 14b–14d
were prepared by the same procedure.
7. Konigsberg W, Hill RH, Craig LC (1961) The oxidation and acid
isomerization of bacitracin A. J Org Chem 26:3867–3871
8. Hirotsu Y, Shiba T, Kaneko T (1970) Synthetic studies on bacitracin.
VII. Isomerization ofamino acid components of thiazoline peptides.
Bull Chem Soc Jpn 43:1870–1873
9. Yonetani K, Hirotsu Y, Shiba T (1975) Racemization of amino acid
residues fused in thiazoline, oxazoline, and imidazoline rings. Bull
Chem Soc Jpn 48:3302–3305
10. Zou B, Long K, Ma D (2005) Total synthesis and cytotoxicity stud-
ies of a cyclic depsipeptide with proposed structure of palau’amide.
Org Lett 7:4237–4240
11. Sugiyama H, Watanabe A, Teruya T, Suenaga K (2009) Synthesis of
palau’amide and its diastereomers: confrmation of its stereostruc-
ture. Tetrahedron Lett 50:7343–7345
12. Ma B, Litvinov DN, He L, Banerjee B, Castle SL (2009) Total syn-
thesis of celogentin C. Angew Chem Int Ed 48:6104–6107
13. Ma B, Banerjee B, Litvinov DN, He L, Castle SL (2010) Total syn-
thesis of the antimitotic bicyclic peptide celogentin C. J Am Chem
Soc 132:1159–1171
Natural 1 (ca 0.1 mg) and synthetic 1 (ca 0.1 mg) were
hydrolyzed with 6 M HCl (200 μL) for 12 h at 105 °C,
and then dried in vacuo. The obtained hydrolysate was
dissolved in MeOH (100 μL), to which SOCl2 (10 μL)
was added at 0 °C. After 30 min the solution was dried
in vacuo. The obtained mixture was dissolved in H2O
(50 μL), to which 1 M NaHCO3 (20 μL) was added. The
hydrolysate added l-FDVDA (0.5% w/v in acetone, 20 μL),
and the mixtures were stirred for 2 h at 50 °C. The solution
was cooled to room temperature, neutralized with 2 M HCl
(20 μL), evaporated, dissolved in MeCN (100 μL), fltered
through a membrane filter (SHIMADZU, TORAST™
DISC, PTFE 0.22 μm), and then analyzed by LC–MS with
14a–14d [column: Cadenza CD-C18, 3.0 × 150 mm; elu-
ent: MeCN/H2O/formic acid = 60/40/0.1 (isocratic min),
0.2 mL/min; detection: ESI-positive].
14. Kuranaga T, Sesoko Y, Sakata K, Maeda N, Hayata A, Inoue M
(2013) Total synthesis and complete structural assignment of
yaku’amide A. J Am Chem Soc 135:5467–5474
15. Kuranaga T, Mutoh H, Sesoko Y, Goto T, Matsunaga S, Inoue M
(2015) Elucidation and total synthesis of the correct structures of tri-
decapeptides yaku’amides A and B. Synthesis-driven stereochemi-
cal reassignment of the four amino acid residues. J Am Chem Soc
137:9443–9451
16. Mutoh H, Sesoko Y, Kuranaga T, Itoh H, Inoue M (2016) Total
synthesis and functional evaluation of fourteen stereoisomers of
yaku’amide B. Importance of stereochemistry for hydrophobicity
and cytotoxicity. Org Biomol Chem 14:4199–4204
17. Marfey P (1984) Determination of D-amino acids. II. Use of a
bifunctional reagent, 1,5-difuoro-2,4-dinitrobenzene. Carlsberg
Res Commun 49:591–596
18. Yamashita T, Matoba H, Kuranaga T, Inoue M (2014) Total syn-
theses of nobilamides B and D: application of traceless Staudinger
ligation. Tetrahedron 70:7746–7752
Acknowledgments This work was fnancially supported in part by a
Grant-in-Aid for Scientifc Research from the Ministry of Education,
Culture, Sports, Science and Technology, Japan [17H06401 (H.K.),
18K14396 (T.K.), and 19H02840 (H.K.)], and the Platform Project
for Supporting Drug Discovery and Life Science Research from the
Japan Agency for Medical Research and Development (AMED), Japan.
Contributions from the SUNBOR GRANT, the Daiichi-Sankyo Award
in The Society of Synthetic Organic Chemistry Japan, the Takeda Sci-
ence Foundation, and The Tokyo Biochemical Research Foundation to
T.K. are also greatly appreciated.
19. Kuranaga T, Minote M, Morimoto R, Pan C, Ogawa H, Kakeya H
(2020) Highly sensitive labeling reagents for scarce natural products.
ACS Chem Biol 15:2499–2506
20. Nakanishi K, Berova N, Woody RW (1994) Circular dichroism,
principles and applications. VCH Publishers Inc., New York
Publisher’s Note Springer Nature remains neutral with regard to
jurisdictional claims in published maps and institutional afliations.
1 3